FindTrial
Sign In

Chromosome aberration analysis of peripheral lymphocytes for the patients who was diagnosed as uterine corpus cancer and receiving adjuvant radiation therapy

Chromosome aberration analysis of peripheral lymphocytes for the patients who was diagnosed as uterine corpus cancer an receiving adjuvant radiation therapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006052
Enrollment
12
Registered
2021-04-05
Start date
2021-12-20
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Korea Cancer Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Female patients, age = 19 years 2. Patients with 0-2 Eastern Cooperative Oncology Group (ECOG) score 3. Patients who was diagnosed as uterine corpus cancer and receiving surgery 4. Patients who singed in written informed consent form to participate in this study after receiving explanation about study goal and procedure

Exclusion criteria

Exclusion criteria: 1. Patients who are pregnant or breastfeeding 2. Patients who previously received chemotherapy or radiotherapy 3. Patients whose treatment area is not whole pelvic 4. Patients whose daily dose is not 1.8 Gy 5. Patients whose total treatment dose is not 50.4 Gy or patients who received brachytherapy

Design outcomes

Primary

MeasureTime frame
Dicentric freqency—

Secondary

MeasureTime frame
translocation frequency—

Countries

Korea, Republic of

Contacts

Public ContactYang Hee Lee

Korea Cancer Center Hospital

highfive1313@kirams.re.kr+82-2-3399-5957

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026